Globus Medical (GMED) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.86% |
| Dec 31, 2025 | 1.32% |
| Sep 30, 2025 | -64.10% |
| Jun 30, 2025 | -146.31% |
| Mar 31, 2025 | 120.98% |
| Dec 31, 2024 | -23.64% |
| Sep 30, 2024 | -1.83% |
| Jun 30, 2024 | 22.34% |
| Mar 31, 2024 | 2.85% |
| Sep 30, 2023 | 0.15% |
| Jun 30, 2023 | 24.09% |
| Mar 31, 2023 | 17.04% |
| Dec 31, 2022 | -28.34% |
| Sep 30, 2022 | -12.42% |
| Jun 30, 2022 | 20.75% |
| Mar 31, 2022 | -4.92% |
| Dec 31, 2021 | -28.50% |
| Sep 30, 2021 | 31.67% |
| Jun 30, 2021 | 57.90% |
| Mar 31, 2021 | -28.21% |
| Dec 31, 2020 | -25.73% |
| Sep 30, 2020 | 18.49% |
| Jun 30, 2020 | 41.59% |
| Mar 31, 2020 | 43.18% |
| Dec 31, 2019 | 16.99% |
| Sep 30, 2019 | -29.35% |
| Jun 30, 2019 | -33.69% |
| Mar 31, 2019 | -20.75% |
| Sep 30, 2018 | -23.71% |
| Jun 30, 2018 | -0.84% |
| Mar 31, 2018 | 10.91% |
| Dec 31, 2017 | -17.81% |
| Sep 30, 2017 | -25.67% |
| Jun 30, 2017 | -53.92% |
| Mar 31, 2017 | -11.60% |
| Dec 31, 2016 | -59.26% |
| Sep 30, 2016 | -66.19% |